BeStock  
Markets › Compare › CRMD vs GYRE

CRMD vs GYRE

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CRMD · CorMedix$5.27 ▲ 3.74%
GYRE · Gyre Therapeutics$4.21 ▼ 6.86%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

416488111135Nov 24, '25May 26, '26Nov 20, '26
  • CRMD -46.3%
  • GYRE -46.5%

Head to head

MetricCRMDGYRE
Price$5.27$4.21
Change today▲ 3.74%▼ 6.86%
Market cap$419.16M$460.79M
Return, 3 months-36.4%-34.6%
Return, year to date-54.7%-40.4%
Return, 1 year-45.6%-44.2%
P/E (TTM)8.2–
P/B0.94.3
P/E percentile vs own 5y89th10th
Dividend yield––
Revenue growth (YoY, latest qtr)-50.8%+0.7%
Net profit growth (YoY)-113.6%-228.6%
Gross margin77.0%93.5%
Operating margin39.4%-16.6%
Net margin15.6%-22.7%
Return on equity15.1%-23.8%
Analyst target vs. price+165.7%+327.6%
Analyst buy share100%100%
RSI (14)4037
30-day volatility108.1%133.1%
Max drawdown, 1 year-64.7%-54.2%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • GYRE is the largest of the group by market value.
  • GYRE has returned the most over the past year.
  • GYRE is growing revenue fastest.
  • CRMD keeps the most profit per dollar of sales.
  • CRMD has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top